Jaundice in Infants and Children

Total Page:16

File Type:pdf, Size:1020Kb

Jaundice in Infants and Children 431 ULTRASOUND CLINICS Ultrasound Clin 1 (2006) 431–441 Jaundice in Infants and Children Marilyn J. Siegel, MD - Sonographic examination Spontaneous perforation of the - Overview of cholestatic diseases extrahepatic bile ducts - Neonatal jaundice Inspissated bile syndrome Biliary atresia - Jaundice in older infants and children Neonatal hepatitis syndrome Caroli disease Additional imaging studies to Byler disease differentiate atresia and hepatitis Hepatocellular diseases Alagille syndrome Inflammatory diseases of the biliary ducts Choledochal cyst Biliary tract obstruction - References Real-time sonography remains the screening echogenicity of the normal liver is low to medium study of choice for the evaluation of jaundice in and homogeneous, and the central portal venous infants and children and it is an important tool in vasculature is easily seen (Fig. 1). In the neonate differentiating between obstructive and nonob- and young infant, the hepatic parenchyma and re- structive causes of jaundice [1,2]. The causes of nal cortex are equally echogenic. In individuals 6 cholestasis are multiple, but the three major causes months of age and older, the liver usually is more are hepatitis, biliary atresia, and choledochal cyst. echogenic than the kidney. The patency and flow Other causes include neoplastic processes, cirrhosis, direction of the hepatic vessels should be do- and strictures. cumented with pulsed and color Doppler interroga- This article reviews the common congenital and tion. The liver and adjacent area should also be acquired causes of jaundice in the pediatric patient evaluated for evidence of end-stage liver disease, in- and describes the sonographic findings associated cluding collateral channels (varices), hepatofugal with these conditions. The role of correlative imag- flow, and ascites. ing studies is also reviewed. The diameter of the common duct should be measured on the sagittal scan to confirm the pres- ence or absence of ductal dilatation. The upper Sonographic examination limits of the common duct should not exceed 1 The sonographic examination of infants and chil- mm in neonates, 2 mm in infants up to 1 year of dren who have jaundice includes a detailed exami- age, 4 mm in children 1 to 10 years of age, and 6 nation of the liver, bile ducts, gallbladder, and mm in adolescents and young adults [3]. The distal pancreas. Hepatic size and echotexture should be portion of the common duct is typically larger than thoroughly assessed. The right hepatic lobe should the proximal portion. Ductal size may increase by extend to or just below the right costal margin 1 mm or more during deep inspiration and the in a patient without hyperinflated lungs. The Valsalva maneuver [4]. The cystic duct in children Radiology and Pediatrics, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Boulevard, St. Louis, MO, 63110, USA E-mail address: [email protected] 1556-858X/06/$ – see front matter ª 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.cult.2006.05.010 ultrasound.theclinics.com 432 Siegel (1) neonatal and (2) older child and adolescent. In the neonate, biliary atresia, the neonatal hepatitis syndrome, and choledochal cyst are the most com- mon causes of jaundice [7–9]. Other causes include syndromic and nonsyndromic bile duct paucity, in- spissated bile syndrome, and spontaneous perfora- tion of the extrahepatic bile duct. In older children, jaundice is most often caused by hepatocellular dis- ease, including hepatitis and cirrhosis. Biliary tract obstruction is a less common cause of childhood jaundice. The possible causes of obstructive jaun- dice include choledochal cyst, cholangitis, stricture, stones, and neoplasms. The results of various laboratory tests of liver function, in conjunction with the pertinent histori- Fig. 1. Normal liver. Transverse sonogram shows ho- cal and physical findings, generally suffice to differ- mogeneous hepatic parenchyma. The echogenic por- entiate between obstructive and nonobstructive tal venous vasculature (arrows) is easily seen. The causes of jaundice. Imaging examinations are used gallbladder (GB) is distended and the wall is thin to confirm the clinical impression. In patients and hyperechoic. PV, portal vein. who have obstructive jaundice, these studies may also often show the level and cause of obstruction. Sonography is the preliminary imaging proce- is not routinely seen unless it is dilated, and then dure. If the extrahepatic ducts are well visualized usually only the distal part of the duct near its inser- by sonography and are normal in caliber and there tion into the common bile duct is seen. is no evidence of intraductal dilatation, further ra- Gallbladder size usually can be assessed subjec- diologic evaluation is rarely needed. Sonography tively, but measurements may be helpful in equivo- is supplemented by radionuclide studies using hep- cal cases. The normal gallbladder length is 1.5 to atobiliary agents (99mTc-IDA analogs) when func- 3.0 cm in neonates and young infants (younger than tional information is needed. Hepatobiliary 1 year old) and the width is approximately 1 cm. In scintigraphy currently is used primarily to confirm older children and adolescents, gallbladder length is suspected diagnoses of choledochal cysts, biliary 3 to 8 cm and width is less than 3.5 cm. The wall of atresia, and neonatal hepatitis. CT or MR imaging the gallbladder should be thin, hyperechoic, and are reserved for cases in which more anatomic de- well defined. The upper limits of wall thickness in tail is needed for surgical planning or the level the fasting state are 3 mm [5]. or cause of obstruction cannot be determined by Feeding of a fatty meal may be helpful in patients sonography [10–15]. who have enlarged gallbladders to assess cystic duct patency. In healthy individuals, maximum empty- ing of the gallbladder occurs between 45 and 60 Neonatal jaundice minutes after the fatty meal, and the mean volume Biliary atresia decreases approximately 60%. Contraction of the Biliary atresia is a rare disease with an incidence of 1 gallbladder after a fatty meal supports the diagnosis in 8,000 to 10,000 live births. It is, however, the sin- of a patent cystic duct. gle most common cause of neonatal cholestasis, ac- Pancreatic size, echotexture, and ductal size should counting for nearly 90% of the surgical causes and be evaluated. Pancreatic size increases with increas- for approximately 40% of all causes of cholestasis ing age of the child [6]. The mean cross-sectional di- [16]. The cause is unclear, but it is believed to be ameter of the pancreatic head ranges between 1 and caused by in utero inflammation that results in fail- 2 cm, the body between 0.6 and 1.1 cm, and the tail ure of the remodeling process at the hepatic hilum between 1 and 2 cm. The normal pancreas is iso- [7]. Histologically, it is characterized by absence of echoic or minimally hyperechoic compared with the extrahepatic bile ducts, proliferation of the the liver. The cross-sectional diameter of the pancre- small intrahepatic bile ducts, periportal fibrosis, atic duct should not exceed 1 to 2 mm. and occasionally multinucleated giant cells. There is a spectrum of changes, depending on the extent of the obliterative process. Complete atresia is pres- Overview of cholestatic diseases ent in 75% to 85% of cases. In the remaining cases, Causes of cholestasis vary with patient age. For this there may be patency of the gallbladder and cystic review, diseases are classified into two main classes: duct or patency of only the gallbladder. Associated Jaundice in Infants & Children 433 anomalies are common (10%–20% of patients) and include choledochal cyst, polysplenia, pre-duo- denal portal vein, azygous continuation of the infe- rior vena cava, diaphragmatic hernia, situs inversus, and hydronephrosis [16–18]. Patients who have biliary atresia and neonatal hepatitis usually present at 1 to 4 weeks of age with jaundice. Distinguishing between neonatal hepatitis and biliary atresia is important, because biliary atresia requires early surgical intervention to prevent biliary cirrhosis, whereas neonatal hep- atitis is managed medically. Surgical treatment varies with the level of obstruction [7,8]. When there is extrahepatic biliary obstruction (15%– 25% of cases), a direct anastomosis between the patent portion of the extrahepatic bile duct and in- testine is performed. When there is intrahepatic Fig. 2. Biliary atresia, cord sign. Transverse sonogram biliary atresia, a Kasai hepatoportoenterostomy through the porta hepatis shows an echogenic cord (anastomosis of a segment of small bowel to the (arrowheads) anterior to the portal vein (arrow), indi- portal region) is performed [7,8,19]. The success cating fibrosis along the course of the common he- rate of the Kasai procedure is inversely propor- patic duct. tional to patient age. Bile flow can be re-estab- lished in up to 90% of infants who are younger Neonatal hepatitis syndrome than 2 months of age at the time of hepatopor- toenterostomy and in approximately 50% in those The neonatal hepatitis syndrome is the term given who are 2 to 3 months. The success rate decreases to nonspecific hepatic inflammation that develops to less than 20% when surgery is performed after secondary to several different causes, including in- 90 days of age because of the presence of cirrhosis fection (cytomegalovirus, herpes simplex, toxoplas- [7–9]. Liver transplantation is often required in mosis, protozoa, syphilis), metabolic defects (alpha older infants and children who have intrahepatic 1-antitrypsin deficiency, galactosemia, glycogen biliary atresia. storage disease, tyrosinosis), and Alagille syndrome. A spectrum of findings may be seen sonograph- ically, reflecting the underlying histology. The liver size and parenchymal echogenicity may be normal or increased [1]. The intrahepatic ducts are typi- cally not dilated. The extrahepatic duct is typically not visualized. A remnant of the extrahepatic duct, however, may be noted in the porta hepatis [20– 23]. This remnant appears as a triangular or tubu- lar echogenic structure just superior to the portal vein bifurcation.
Recommended publications
  • Clinical Classification of Caroli's Disease: an Analysis of 30 Patients
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector DOI:10.1111/hpb.12330 HPB ORIGINAL ARTICLE Clinical classification of Caroli's disease: an analysis of 30 patients Zhong-Xia Wang1,2*, Yong-Gang Li2*, Rui-Lin Wang2, Yong-Wu Li3, Zhi-Yan Li3, Li-Fu Wang2, Hui-Ying Yang2, Yun Zhu2, Yao Wang2, Yun-Feng Bai2, Ting-Ting He2, Xiao-Feng Zhang2 & Xiao-He Xiao1,2 1Department of Graduate School, 301 Hospital, 2Integrative Medical Centre, and 3Imaging Centre, 302 Hospital, Beijing, China Abstract Background: Caroli's disease (CD) is a rare congenital disorder. The early diagnosis of the disease and differentiation of types I and II are of extreme importance to patient survival. This study was designed to review and discuss observations in 30 patients with CD and to clarify the clinical characteristics of the disease. Methods: The demographic and clinical features, laboratory indicators, imaging findings and pathology results for 30 patients with CD were reviewed retrospectively. Results: Caroli's disease can occur at any age. The average age of onset in the study cohort was 24 years. Patients who presented with symptoms before the age of 40 years were more likely to develop type II CD. Approximately one-third of patients presented without positive signs at original diagnosis and most of these patients were found to have type I CD on pathology. Anaemia, leucopoenia and thrombocytopoenia were more frequent in patients with type II than type I CD. Magnetic resonance cholangiopancreatography (MRCP) and computed tomography (CT) examinations were most useful in diagnosing CD.
    [Show full text]
  • Biliary Tract
    2016-06-16 The role of cytology in management of diseases of hepatobiliary ducts • Diagnosis in patients with radiologically/clinically detected lesions • Screening of dysplasia/CIS/cancer in risk groups biliary tract cytology • Preoperative evaluation of the candidates for liver transplantation (Patients with cytological low-grade and high-grade Mehmet Akif Demir, MD dysplasia/adenocarcinoma are currently referred for liver transplantation Sahlgrenska University Hospital in some institutions). Gothenburg Sweden Sarajevo 18th June 2016 • Diagnosis of the benign lesions and infestations False positive findings • majority of false positive cases have a Low sensitivity but high specificity! background of primary sclerosing cholangitis. – lymphoplasmacytic sclerosing pancreatitis and cholangitis, – primary sclerosing cholangitis, – granulomatous disease, – non-specific fibrosis/inflammation – stone disease. False negative findings • Repeat brushing increases the diagnostic yield and should be performed when sampling • Poor sampling biliary strictures with a cytology brush at ERCP. • Lack of diagnostic criteria for dysplasia-carcinoma in situ • Difficulties in recognition of special tumour types – well-differentiated cholangiocarcinoma with tubular architecture • Predictors of positive yield include – gastric foveolar type cholangiocarcinoma with mucin-producing – tumour cells. older age, •Underestimating the significance of the smear background – mass size >1 cm, and – stricture length of >1 cm. •The causes of false negative cytology –sampling
    [Show full text]
  • Journal of Medical Genetics April 1992 Vol 29 No4 Contents Original Articles
    Journal of Medical Genetics April 1992 Vol 29 No4 Contents Original articles Beckwith-Wiedemann syndrome: a demonstration of the mechanisms responsible for the excess J Med Genet: first published as on 1 April 1992. Downloaded from of transmitting females C Moutou, C Junien, / Henry, C Bonai-Pellig 217 Evidence for paternal imprinting in familial Beckwith-Wiedemann syndrome D Viljoen, R Ramesar 221 Sex reversal in a child with a 46,X,Yp+ karyotype: support for the existence of a gene(s), located in distal Xp, involved in testis formation T Ogata, J R Hawkins, A Taylor, N Matsuo, J-1 Hata, P N Goodfellow 226 Highly polymorphic Xbol RFLPs of the human 21 -hydroxylase genes among Chinese L Chen, X Pan, Y Shen, Z Chen, Y Zhang, R Chen 231 Screening of microdeletions of chromosome 20 in patients with Alagille syndrome C Desmaze, J F Deleuze, A M Dutrillaux, G Thomas, M Hadchouel, A Aurias 233 Confirmation of genetic linkage between atopic IgE responses and chromosome 1 1 ql 3 R P Young, P A Sharp, J R Lynch, J A Faux, G M Lathrop, W 0 C M Cookson, J M Hopkini 236 Age at onset and life table risks in genetic counselling for Huntington's disease P S Harper, R G Newcombe 239 Genetic and clinical studies in autosomal dominant polycystic kidney disease type 1 (ADPKD1) E Coto, S Aguado, J Alvarez, M J Menendez-DIas, C Lopez-Larrea 243 Short communication Evidence for linkage disequilibrium between D16S94 and the adult onset polycystic kidney disease (PKD1) gene S E Pound, A D Carothers, P M Pignatelli, A M Macnicol, M L Watson, A F Wright 247 Technical note A strategy for the rapid isolation of new PCR based DNA polymorphisms P R Hoban, M F Santibanez-Koref, J Heighway 249 http://jmg.bmj.com/ Case reports Campomelic dysplasia associated with a de novo 2q;1 7q reciprocal translocation I D Young, J M Zuccollo, E L Maltby, N J Broderick 251 A complex chromosome rearrangement with 10 breakpoints: tentative assignment of the locus for Williams syndrome to 4q33-q35.1 R Tupler, P Maraschio, A Gerardo, R Mainieri G Lanzi L Tiepolo 253 on September 26, 2021 by guest.
    [Show full text]
  • Chromosome 20
    Chromosome 20 ©Chromosome Disorder Outreach Inc. (CDO) Technical genetic content provided by Dr. Iosif Lurie, M.D. Ph.D Medical Geneticist and CDO Medical Consultant/Advisor. Ideogram courtesy of the University of Washington Department of Pathology: ©1994 David Adler.hum_20.gif Introduction Chromosome 20 contains about 2% of the whole genetic material. Its genetic length is ~63 Mb. The long arm (~36 Mb) is a little bit larger than the short arm (~27 Mb). Chromosome 20 contains ~700–800 genes. Less than 10% of these genes are known to be related to human diseases. Deletions or duplications of these genes, which may be found in patients with chromosomal abnormalities, cause mostly functional defects, including a delay of psycho–motor development and seizures. Only a few genes may lead (when deleted) to structural defects of the heart, liver, extremities and other organs. Deletions of Chromosome 20 There is a relatively small number of known conditions caused by deletions and duplications of various segments of chromosome 20. Almost all of these deletions and duplications became recognized after usage of molecular cytogenetics. Only a handful of reports on patients with these abnormalities were available only 10 years ago. Because these methods open wide an opportunity to examine abnormalities of this previously not–well studied chromosome, there are no doubts that some new syndromes caused by deletions (or duplications) of chromosome 20 will be delineated in the near future. Currently, the most frequent forms of chromosome 20 deletions are deletions 20p12, involving the JAG1 gene and Alagille syndrome, and deletions 20q13.13q13.2, involving the SALL4 gene.
    [Show full text]
  • Its Place Among Other Genetic Causes of Renal Disease
    J Am Soc Nephrol 13: S126–S129, 2002 Anderson-Fabry Disease: Its Place among Other Genetic Causes of Renal Disease JEAN-PIERRE GRU¨ NFELD,* DOMINIQUE CHAUVEAU,* and MICHELINE LE´ VY† *Service of Nephrology, Hoˆpital Necker, Paris, France; †INSERM U 535, Baˆtiment Gregory Pincus, Kremlin- Biceˆtre, France. In the last two decades, decisive advances have been made in Nephropathic cystinosis, first described in 1903, is an auto- the field of human genetics, including renal genetics. The somal recessive disorder characterized by the intra-lysosomal responsible genes have been mapped and then identified in accumulation of cystine. It is caused by a defect in the transport most monogenic renal disorders by using positional cloning of cystine out of the lysosome, a process mediated by a carrier and/or candidate gene approaches. These approaches have that remained unidentified for several decades. However, an been extremely efficient since the number of identified genetic important management step was devised in 1976, before the diseases has increased exponentially over the last 5 years. The biochemical defect was characterized in 1982. Indeed cysteam- data derived from the Human Genome Project will enable a ine, an aminothiol, reacts with cystine to form cysteine-cys- more rapid identification of the genes involved in the remain- teamine mixed disulfide that can readily exit the cystinotic ing “orphan” inherited renal diseases, provided their pheno- lysosome. This drug, if used early and in high doses, retards the types are well characterized. We have entered the post-gene progression of cystinosis in affected subjects by reducing intra- era. What is/are the function(s) of these genes? What are the lysosomal cystine concentrations.
    [Show full text]
  • ULTRASOUND STUDY GUIDE • Technical Knowledge O Physics And
    ULTRASOUND STUDY GUIDE Technical knowledge o Physics and Safety, understand the following: 1) Physics of sound interactions in the body. 2) How transducers work, how the image is created, and what physical properties are being displayed. 3) Relative strengths and weaknesses of different transducers including various aspects of resolution. Sound properties and interactions Reflection Attenuation Scattering Refraction Absorption Acoustic impedance Speed of sound Wavelength Other . Transducer fundamentals Transmit frequencies Transducer components Transducer types Transducer pros and cons Other . Beam formation Focusing Steering Other . Imaging modes and display 2D 3D 4D Panoramic imaging Compound imaging Harmonic imaging Elastography Contrast imaging Scanning modes o 2D o 3D o 4D o M-mode o Doppler o Other Image orientation Other . Image resolution Axial Lateral Elevational / Azimuthal Temporal Contrast Penetration vs. resolution Other . System Controls - Know the function of the controls listed below and be able to recognize them in the list of scan parameters shown on the image monitor Gain Time gain compensation Power output Focal zone Transmit frequency Depth Width Zoom / Magnification Dynamic range Frame rate Line density Frame averaging / persistence Other . Doppler / Flow imaging – Be familiar with the terminology used to describe Doppler exams. Be able to interpret and optimize the images. Be able to recognize artifacts, know their significance, and know what produces them. Doppler
    [Show full text]
  • Guideline for the Evaluation of Cholestatic Jaundice
    CLINICAL GUIDELINES Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition ÃRima Fawaz, yUlrich Baumann, zUdeme Ekong, §Bjo¨rn Fischler, jjNedim Hadzic, ôCara L. Mack, #Vale´rie A. McLin, ÃÃJean P. Molleston, yyEzequiel Neimark, zzVicky L. Ng, and §§Saul J. Karpen ABSTRACT Cholestatic jaundice in infancy affects approximately 1 in every 2500 term PREAMBLE infants and is infrequently recognized by primary providers in the setting of holestatic jaundice in infancy is an uncommon but poten- physiologic jaundice. Cholestatic jaundice is always pathologic and indicates tially serious problem that indicates hepatobiliary dysfunc- hepatobiliary dysfunction. Early detection by the primary care physician and tion.C Early detection of cholestatic jaundice by the primary care timely referrals to the pediatric gastroenterologist/hepatologist are important physician and timely, accurate diagnosis by the pediatric gastro- contributors to optimal treatment and prognosis. The most common causes of enterologist are important for successful treatment and an optimal cholestatic jaundice in the first months of life are biliary atresia (25%–40%) prognosis. The Cholestasis Guideline Committee consisted of 11 followed by an expanding list of monogenic disorders (25%), along with many members of 2 professional societies: the North American Society unknown or multifactorial (eg, parenteral nutrition-related) causes, each of for Gastroenterology, Hepatology and Nutrition, and the European which may have time-sensitive and distinct treatment plans. Thus, these Society for Gastroenterology, Hepatology and Nutrition. This guidelines can have an essential role for the evaluation of neonatal cholestasis committee has responded to a need in pediatrics and developed to optimize care.
    [Show full text]
  • Focal Liver Hyperplasia in Alagille Syndrome: Assessment with Hepatoreceptor and Hepatobiliary Imaging
    Focal Liver Hyperplasia in Alagille Syndrome: Assessment with Hepatoreceptor and Hepatobiliary Imaging Tatsuo Torizuka, Nagara Tamaki, Toru Fujita, Yoshiharu Yonekura, Shinji Uemoto, Koichi Tanaka, Yoshio Yamaoka and Junj i Konishi Department of Nuclear Medicine and Second Department of Surgery, Kyoto University Faculty of Medicine, Kyoto, Japan manifestations of Alagille syndrome, including hypertelorism, A child with Alagille syndrome, characterized by intrahepatic bile broad forehead, high nose and pointed chin. The patient's mother duct paucity, developed severe liver cirrhosis and was referred for liver transplantation. In the pre-transplantation evaluation, scinti- did not have the same facial features. graphic scans were performed using 99mTc-galactosyl serum albu Cholecystectomy was performed for cholestasis when the patient min (""Tc-GSA) as a hepatoreceptor binding agent and 99mTc- was 5 yr old. At 6 yr, severe liver cirrhosis was suspected based on pyridoxyl-5-methyl-tryptophan (""Tc-PMT) as a hepatobiliary serum biochemical data. The serum direct bilirubin value was 21.5 agent. These studies demonstrated severe hepatobiliary dysfunc mg/dl. Jaundice and marked venous dilatation on the abdominal tion with an area of increased focal uptake in the liver. Histological wall were observed. X-ray CT images revealed liver atrophy with examination at surgery confirmed that this focal lesion was an area splenomegaly and a high density nodular lesion in the medial right of compensatory hyperplasia in advanced biliary cirrhosis. We lobe of the liver (Fig. 1). present the usefulness of these tracers for detecting the focal The patient underwent dynamic 99Tc-GSA imaging under a hyperplasia of the liver. rotating gamma camera.
    [Show full text]
  • Essential Genetics 5
    Essential genetics 5 Disease map on chromosomes 例 Gaucher disease 単一遺伝子病 天使病院 Prader-Willi syndrome 隣接遺伝子症候群,欠失が主因となる疾患 臨床遺伝診療室 外木秀文 Trisomy 13 複数の遺伝子の重複によって起こる疾患 挿画 Koromo 遺伝子の座位あるいは欠失等の範囲を示す Copyright (c) 2010 Social Medical Corporation BOKOI All Rights Reserved. Disease map on chromosome 1 Gaucher disease Chromosome 1q21.1 1p36 deletion syndrome deletion syndrome Adrenoleukodystrophy, neonatal Cardiomyopathy, dilated, 1A Zellweger syndrome Charcot-Marie-Tooth disease Emery-Dreifuss muscular Hypercholesterolemia, familial dystrophy Hutchinson-Gilford progeria Ehlers-Danlos syndrome, type VI Muscular dystrophy, limb-girdle type Congenital disorder of Insensitivity to pain, congenital, glycosylation, type Ic with anhidrosis Diamond-Blackfan anemia 6 Charcot-Marie-Tooth disease Dejerine-Sottas syndrome Marshall syndrome Stickler syndrome, type II Chronic granulomatous disease due to deficiency of NCF-2 Alagille syndrome 2 Copyright (c) 2010 Social Medical Corporation BOKOI All Rights Reserved. Disease map on chromosome 2 Epiphyseal dysplasia, multiple Spondyloepimetaphyseal dysplasia Brachydactyly, type D-E, Noonan syndrome Brachydactyly-syndactyly syndrome Peters anomaly Synpolydactyly, type II and V Parkinson disease, familial Leigh syndrome Seizures, benign familial Multiple pterygium syndrome neonatal-infantile Escobar syndrome Ehlers-Danlos syndrome, Brachydactyly, type A1 type I, III, IV Waardenburg syndrome Rhizomelic chondrodysplasia punctata, type 3 Alport syndrome, autosomal recessive Split-hand/foot malformation Crigler-Najjar
    [Show full text]
  • Solitary Cystic Dilatation of the Intrahepatic Bile
    Short reports 617 Solitary cystic dilatation of the intrahepatic bile duct J Clin Pathol: first published as 10.1136/jcp.50.7.617 on 1 July 1997. Downloaded from K Ohmoto, M Shimizu, Y Iguchi, S Yamamoto, M Murakami, T Tsunoda Abstract presented with neither a pertinent family A 31 year old man was hospitalised with history nor a personal history of blood transfu- general fatigue and epigastric pain. Ab- sion, tattooing, or drug abuse. On physical dominalultrasonography, computedtomo- examination, there was a slight tenderness in graphy, and magnetic resonance imaging the epigastrium and right hypochondrium, and showed a cystic lesion in the left lobe ofthe the liver was slightly enlarged. Results of liver liver. Endoscopic retrograde cholangio- function tests were: total bilirubin, 2.1 mg/l pancreatography and percutaneous trans- (normal value 0.2-1.0); alkaline phosphate, hepatic cholangiography revealed a 127 IU/l (28-84); 7 glutamyltranspeptidase localised dilatation ofthe intrahepatic bile 314 IU/l (4-30); aspartate aminotransferase duct without any obstruction. However, a 117 IU/l (7-20); and alanine aminotransferase large mass of mucinous material was 425 IU/l (7-28). Virus markers were negative noted in the saccular intrahepatic duct for hepatitis A, B, and C. Abdominal ultra- and the common bile duct. There was no sonography, computed tomography, and mag- evidence of a choledochal cyst, anomalous netic resonance imaging showed a cystic lesion pancreaticobiliary ductal union, or con- in the left lobe of the liver. Choledochal cysts genital cystic change of the kidneys. A and anomalous pancreaticobiliary ductal union possible diagnosis ofmucinous cystic neo- were not demonstrated on endoscopic retro- plasm of the intrahepatic bile duct was grade cholangiopancreatography.
    [Show full text]
  • Outcome of Liver Disease in Children with Alagille Syndrome: a Study of 163 Patients Gut: First Published As 10.1136/Gut.49.3.431 on 1 September 2001
    Gut 2001;49:431–435 431 Outcome of liver disease in children with Alagille syndrome: a study of 163 patients Gut: first published as 10.1136/gut.49.3.431 on 1 September 2001. Downloaded from P Lykavieris, M Hadchouel, C Chardot, O Bernard Abstract to have a relatively good long term prognosis in Background and aims—Various opinions terms of liver disease45; however, it is now well have been expressed as to the long term recognised that some patients with AGS can prognosis of liver disease associated with present with severe complications of liver Alagille syndrome (AGS). disease.6–12 We therefore reviewed the charts of Patients and methods—We reviewed the 174 patients with AGS presenting in childhood outcome of 163 children with AGS and to evaluate the role of the liver condition in liver involvement, investigated from 1960 mortality, morbidity, and long term outcome. to 2000, the end point of the study (median age 10 years (range 2 months to 44 years)) being death, liver transplantation, or the Patients and methods last visit. One hundred and seventy four children with Results—At the study end point, of the 132 AGS (106 boys) were investigated at Bicêtre patients who presented with neonatal Hospital between 1960 and 2000. Twenty four cholestatic jaundice, 102 remained jaun- had a sibling aVected by AGS; seven of these diced, 112 had poorly controlled pruritus, siblings are included in this series as well as two and 40 had xanthomas; cirrhosis was oVspring of aVected mothers. All patients had found in 35/76 livers, varices in 25/71 at least three of the five major clinical features.
    [Show full text]
  • EUROCAT Syndrome Guide
    JRC - Central Registry european surveillance of congenital anomalies EUROCAT Syndrome Guide Definition and Coding of Syndromes Version July 2017 Revised in 2016 by Ingeborg Barisic, approved by the Coding & Classification Committee in 2017: Ester Garne, Diana Wellesley, David Tucker, Jorieke Bergman and Ingeborg Barisic Revised 2008 by Ingeborg Barisic, Helen Dolk and Ester Garne and discussed and approved by the Coding & Classification Committee 2008: Elisa Calzolari, Diana Wellesley, David Tucker, Ingeborg Barisic, Ester Garne The list of syndromes contained in the previous EUROCAT “Guide to the Coding of Eponyms and Syndromes” (Josephine Weatherall, 1979) was revised by Ingeborg Barisic, Helen Dolk, Ester Garne, Claude Stoll and Diana Wellesley at a meeting in London in November 2003. Approved by the members EUROCAT Coding & Classification Committee 2004: Ingeborg Barisic, Elisa Calzolari, Ester Garne, Annukka Ritvanen, Claude Stoll, Diana Wellesley 1 TABLE OF CONTENTS Introduction and Definitions 6 Coding Notes and Explanation of Guide 10 List of conditions to be coded in the syndrome field 13 List of conditions which should not be coded as syndromes 14 Syndromes – monogenic or unknown etiology Aarskog syndrome 18 Acrocephalopolysyndactyly (all types) 19 Alagille syndrome 20 Alport syndrome 21 Angelman syndrome 22 Aniridia-Wilms tumor syndrome, WAGR 23 Apert syndrome 24 Bardet-Biedl syndrome 25 Beckwith-Wiedemann syndrome (EMG syndrome) 26 Blepharophimosis-ptosis syndrome 28 Branchiootorenal syndrome (Melnick-Fraser syndrome) 29 CHARGE
    [Show full text]